European Global Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.

Press releases published on September 3, 2026

Sep. 3, 2026

Fortrea Adquire Unidade de Farmacologia Clínica e Operações de Laboratório Bioanalítico da Worldwide Clinical Trials

Indeterminate GlobeNewswire

Sep. 3, 2026

Fortrea 将收购 Worldwide Clinical Trials 的临床药理部门和生物分析实验室业务

Indeterminate GlobeNewswire

Sep. 3, 2026

Fortrea 將收購 Worldwide Clinical Trials 的臨床藥理學部門及生物分析實驗室業務

Indeterminate GlobeNewswire

Sep. 3, 2026

Fortrea เข้าซื้อกิจการหน่วยเภสัชวิทยาคลินิกและการปฏิบัติการห้องปฏิบัติการวิเคราะห์ทางชีวภาพจาก Worldwide Clinical Trial…

Indeterminate GlobeNewswire

Sep. 3, 2026

Virtune Lists Virtune Chainlink ETP on the Warsaw Stock Exchange

Indeterminate GlobeNewswire

Sep. 3, 2026

Virtune wprowadza Virtune Chainlink ETP na Giełdę Papierów Wartościowych w Warszawie

Indeterminate GlobeNewswire

Sep. 3, 2026

iPronics récolte 125 millions de dollars dans le but de développer les réseaux optiques programmables destinés aux centres de données dédiés à l’IA

Indeterminate GlobeNewswire

Sep. 3, 2026

iPronics sichert sich 125 Millionen US-Dollar zur Skalierung programmierbarer optischer Netzwerke für KI-Rechenzentren

Indeterminate GlobeNewswire

Sep. 3, 2026

Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress

Indeterminate GlobeNewswire

Sep. 3, 2026

Tensive to receive €20 million from EIB to commercialize bioresorbable breast implant

Indeterminate GlobeNewswire

Sep. 3, 2026

Egetis Therapeutics to Participate in Upcoming Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 3, 2026

ONWARD Medical Announces First Implant in New Clinical Feasibility Study Evaluating ARC-IM System to Restore Mobility After Spinal Cord Injury

Indeterminate GlobeNewswire

Sep. 3, 2026

Nokia and BeeHealthy bring network-based verification to digital healthcare

Indeterminate GlobeNewswire

Sep. 3, 2026

HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy

Indeterminate GlobeNewswire

Sep. 3, 2026

British Property Entrepreneur Samuel Leeds Takes The Eviction Competition to the US for the First Texas Series

Indeterminate GlobeNewswire